Pathological Fractures in Benign Bone Lesions - Diagnosis and Therapy

Abstract

Introduction Most tumour-related pathological fractures occur in patients with bone metastases. However, in mostly younger patients, a pathological fracture can be due to both a benign or a malignant bone tumour. Making the correct diagnosis from among these two differential diagnoses is enormously important. If the tumour is malignant, treating the fracture inevitably leads to tumour cell contamination and can significantly worsen the oncological situation. The aim of this review article is firstly to provide the reader with diagnostic assistance in the case of suspected pathological fractures, and secondly to focus on the treatment of pathological fractures occurring with benign bone tumours.

Methods This is a non-systematic review of the diagnosis and treatment of pathological fractures in benign bone tumours or tumour-like lesions, based on an electronic PubMed database search. We also present our own procedures, in particular for ruling out a malignant bone tumour.

Results and Discussion Whenever a fracture occurs in the absence of sufficient traumatic force, the possibility of a pathological fracture should always be considered. As well as taking a general history for a possible primary tumour, it is particularly important to ask the patient whether they had any pain before the fracture occurred. If the findings from clinical examination or conventional radiological imaging give rise to suspicion of a pathological fracture, an MRI of the affected skeletal section with contrast medium should be carried out before commencing any fracture treatment. A CT scan is also helpful for accurately assessing bone destruction. If a malignant or locally aggressive benign bone tumour such as giant cell tumour (GCT) or aneurysmal bone cyst (ABC) cannot be definitively ruled out through imaging, a biopsy is essential. The bone biopsy must always be carried out on the assumption that the histological work-up will reveal a malignant bone tumour; it must therefore be performed according to strict oncological criteria. If the radiological diagnosis is unambiguous, e. g., a juvenile bone cyst (JBC) or a non-ossifying fibroma (NOF), conservative treatment of the fracture can be considered, depending on the location. In the presence of a locally aggressive benign bone tumour such as a GCT or ABC, curettage of the tumour must be carried out as well as treating the fracture. With GCT in particular, neoadjuvant therapy with denosumab prior to curettage and osteosynthesis or en bloc resection of the tumour should be considered, depending on the extent of the tumour.

Conclusion Pathological fractures, especially in younger patients, should not be overlooked. Only after a malignant or benign locally aggressive bone tumour has been definitively ruled out should fracture treatment be performed. In the presence of a locally aggressive bone tumour, as well as treating the fracture, it is usually necessary to perform curettage of the tumour – also en bloc resection, where applicable, in the case of a GCT. Depending on the location, benign, non-aggressive tumours can be treated conservatively if necessary.

Keywords

fracture - pathological - bone tumor - benign

Publication History

Received: 28 October 2021

Accepted after revision: 10 May 2022

Article published online:
26 July 2022

• Literatur

• 1 Rupp M, Walter N, Pfeifer C. et al. The incidence of fractures among the adult population of Germany – an analysis from 2009 through 2019. Dt Arztebl Int 2021; 118: 665-669
• 2 Schlegel M, Zeumer M, Prodinger PM. et al. Impact of pathological fractures on the prognosis of primary malignant bone sarcoma in children and adults: a single-center retrospective study of 205 patients. Oncology 2018; 94: 354-362
• 3 Gutowski CJ, Zmistowski B, Fabbri N. et al. Should the use of biologic agents in patients with renal and lung cancer affect our surgical management of femoral metastases?. Clin Orthop Relat Res 2019; 477: 707-714
• 4 Farr S, Spencer Balaco IM, Martinez-Alvarez S. et al. Current trends and variations in the treatment of unicameral bone cysts of the humerus: a survey of EPOS and POSNA members. J Pediatr Orthop 2020; 40: 68-76
• 5 Jamshidi K, Zandrahimi F, Haji Agha Bozorgi M. et al. Extended curettage versus en bloc resection for the treatment of grade 3 giant cell tumour of the knee with pathologic fracture: a retrospective study. Int Orthop 2021; 45: 289-297
• 6 Van der Heijden L, Dijkstra PD, Campanacci DA. et al. Giant Cell Tumor With Pathologic Fracture: Should We Curette or Resect?. Clin Orthop Relat Res 2013; 471: 820-829
• 7 Leet AI, Boyce AM, Ibrahim KA. et al. Bone grafting in polyostotic fibrous dysplasia. J Bone Joint Surg Am 2016; 98: 211-219
• 8 Majoor BC, Peeters-Boef MJ, van de Sande MA. et al. What Is the Role of Allogeneic Cortical Strut Grafts in the Treatment of Fibrous Dysplasia of the Proximal Femur?. Clin Orthop Relat Res 2017; 475: 786-795
• 9 Dorosh J, Vyas P. Aneurysmal Bone Cyst of the Distal Femoral Metaphysis in a Four-year-old Female Patient Presenting with a Pathologic Fracture: A Case Report. Cureus 2019; 11: e4846
• 10 Kadar A, Kleinstern G, Morsy M. et al. Multiple Enchondromas of the Hand in Children: Long-Term Follow-Up of Mean 15.4 Years. J Pediatr Orthop 2018; 38: 543-548
• 11 Arata MA, Peterson HA, Dahlin DC. Pathological fractures through non-ossifying fibromas. Review of the Mayo Clinic experience. J Bone Joint Surg Am 1981; 63: 980-988
• 12 Herget GW, Mauer D, Krauß T. et al. Non-ossifying fibroma: natural history with an emphasis on a stage-related growth, fracture risk and the need for follow-up. BMC Musculoskeletal Disorders 2016; 17: 147
• 13 Kaiser MM. AWMF. S1-Leitlinie: Knochenzysten 006–029. Accessed May 13, 2022 at: https://www.awmf.org/uploads/tx_szleitlinien/006–029l_S1_Knochenzysten_2019–09.pdf
• 14 Ortiz EJ, Isler MH, Navia JE. et al. Pathologic fractures in children. Clin Orthop Relat Res 2005; 432: 116-126
• 15 Tomaszewski R, Rutz E, Mayr J. et al. Surgical treatment of benign lesions and pathologic fractures of the proximal femur in children. Arch Orthop Trauma Surg 2022; 142: 615-624
• 16 Anract P, Biau D, Boudou-Rouquette P. Metastatic fractures of long limb bones. Orthop Traumatol Surg Res 2017; 103: S41-S51
• 17 Slavchev S, Georgiev GP. A Non-ossifying Fibroma and a Stress Fracture of the Femur Mimicking Bone Malignancy in a Child. Cureus 2020; 2: e7652
• 18 Wuennemann F, Kintzele L, Weber MA. et al. Radiologische Diagnostik pathologischer Frakturen. Radiologe 2020; 60: 498-505
• 19 Ozaki T, Hillmann A, Lindner N. et al. Cementation of primary aneurysmal bone cysts. Clin Orthop Relat Res 1997; 337: 240-248
• 20 Canavese F, Alberghina F, Dimeglio A. et al. Displaced distal femur metaphyseal fractures: clinical and radiographic outcome in children aged 6–16 years treated by elastic stable intramedullary nailing. J Pediatr Orthop B 2021; 30: 415-422
• 21 Balke M, Schremper L, Gebert C. et al. Giant cell tumor of bone: treatment and outcome of 214 cases. J Cancer Res Clin Oncol 2008; 134: 969-978
• 22 Palmerini E, Staals EL, Jones LB. et al. Role of (neo-) adjuvant denosumab for giant cell tumor of bone. Curr Treat Options Oncol 2020; 21: 68
• 23 Morii T, Mochizuki K, Tajima T. et al. Treatment outcome of enchondroma by simple curettage without augmentation. J Orthop Sci 2010; 15: 112-117
• 24 Verdegaal SH, Bovee JV, Pansuriya TC. et al. Incidence, predictive factors, and prognosis of chondrosarcoma in patientswith Ollier disease and Maffuccisyndrome: an international multicenter study of 161 patients. Oncologist 2011; 16: 1771-1779
• 25 Streitbuerger A, Ahrens H, Balke M. et al. Grade I chondrosarcoma of bone: the Munster experience. J Cancer Res Clin Oncol 2009; 135: 543-550
• 26 Jurik AG, Holmberg Jørgensen P. et al. Whole-body MRI in assessing malignant transformation in multiple hereditary exostoses and enchondromatosis: audit results and literature review. Skeletal Radiol 2020; 49: 115-124